The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder

Dec 1, 2022·
Daniel Turner
,
Peer Briken
Joshua B. Grubbs
Joshua B. Grubbs
,
Leo Malandain
,
Gemma Mestre-Bach
,
Marc N. Potenza
,
Florence Thibaut
· 0 min read
DOI
Abstract
Objectives The current guidelines aim to evaluate the role of pharmacological agents in the treatment of patients with compulsive sexual behaviour disorder (CSBD). They are intended for use in clinical practice by clinicians who treat patients with CSBD.Methods An extensive literature search was conducted using the English-language-literature indexed on PubMed and Google Scholar without time limit, supplemented by other sources, including published reviews.Results Each treatment recommendation was evaluated with respect to the strength of evidence for its efficacy, safety, tolerability, and feasibility. Psychoeducation and psychotherapy are first-choice treatments and should always be conducted. The type of medication recommended depended mainly on the intensity of CSBD and comorbid sexual and psychiatric disorders. There are few randomised controlled trials. Although no medications carry formal indications for CSBD, selective-serotonin-reuptake-inhibitors and naltrexone currently constitute the most relevant pharmacological treatments for the treatment of CSBD. In cases of CSBD with comorbid paraphilic disorders, hormonal agents may be indicated, and one should refer to previously published guidelines on the treatment of adults with paraphilic disorders. Specific recommendations are also proposed in case of chemsex behaviour associated with CSBD.Conclusions An algorithm is proposed with different levels of treatment for different categories of patients with CSBD.
Type
Publication
Dialogues in Clinical Neuroscience, 24(1)
publications
Joshua B. Grubbs
Authors
Associate Professor of Psychology · Licensed Clinical Psychologist
Joshua Grubbs is an Associate Professor of Psychology at the University of New Mexico and an Investigator at the Center on Alcohol, Substance use, And Addictions (CASAA), where he directs the Behavioral Addictions And Associated Disorders (BAAAD) Lab. His research examines gambling and sports betting, compulsive sexual behavior, and alcohol use, with a focus on how social, moral, and policy contexts shape addictive behavior.